UNSPSC 51342704: Boceprevir

This classification denotes a protease inhibitor and antiviral with the molecular formula C27H45N5O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 89BT58KELH, chemically known as (1R,2S,5S)-N-(4-amino-1-cyclobutyl-3,4-dioxobutan-2-yl)-3-[(2S)-2-(tert-butylcarbamoylamino)-3,3-dimethylbutanoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide but generally known as Boceprevir, which bears US NIH Compound Identifier 10324367. Boceprevir most often comes in base and sulfate forms.

UNSPSC 51342704 Boceprevir, a Commodity code, shows minimal relevant recent state and local procurement activity. The code nominally covers a specific hepatitis C antiviral pharmaceutical, but the recent opportunities tagged under it—naloxone procurement, pharmacy benefit program restructuring, medical and first aid supplies for fire rescue, and generic pharmaceutical cooperative purchasing—do not involve boceprevir or direct pharmaceutical manufacturing for a single active ingredient. State and local governments are not currently soliciting boceprevir as a standalone contracted product through the mechanisms visible in this dataset.

The mismatch between the code's nominal scope and the opportunities tagged to it suggests either miscoding at the point of solicitation posting or that boceprevir procurement is so infrequent or bundled into broader pharmaceutical supply agreements that it does not appear as a discrete buying activity. No issuing body has posted a direct RFP, RFQ, IFB, or ITB for boceprevir itself. The opportunities shown span Seminole County, Florida (naloxone and drug deactivation systems); Texas Health and Human Services Commission (pharmacy benefit program intelligence gathering); City of Tampa (fire rescue medical supplies); and Minnesota Department of Administration via the MMCAP cooperative (generic pharmaceuticals and OTC products). None of these solicitations target boceprevir procurement. Vendors pursuing this code should verify actual demand with state Medicaid agencies and public health departments rather than rely on recent posting activity.